Sodium Molybdate

CAS No. 7631-95-0

Sodium Molybdate( Molybdate disodium )

Catalog No. M20054 CAS No. 7631-95-0

Sodium molybdate is a useful source of molybdate. In murine models Sodium molybdate dihydrate inactivated both the active and inactive form of the glucocorticoid receptor complex.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sodium Molybdate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium molybdate is a useful source of molybdate. In murine models Sodium molybdate dihydrate inactivated both the active and inactive form of the glucocorticoid receptor complex.
  • Description
    Sodium molybdate is a useful source of molybdate. In murine models Sodium molybdate dihydrate inactivated both the active and inactive form of the glucocorticoid receptor complex.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Molybdate disodium
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others
  • Indication
    Skin and hair protectant

Chemical Information

  • CAS Number
    7631-95-0
  • Formula Weight
    205.92
  • Molecular Formula
    MoNa2O4
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:100 mg/mL (485.58 mM)
  • SMILES
    [Na+].[Na+].[O-][Mo]([O-])(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ale-Ebrahim M. Eidi A. Mortazavi P. Tavangar S. & Tehrani D. (2015). Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation.?Journal Of Trace Elements In Medicine And Biology?29 242-248. doi: 10.1016/j.jtemb.2014.07.002
molnova catalog
related products
  • CJJ300

    CJJ300 is a transforming growth factor-β (TGF-β) inhibitor with an IC50 of 5.3 μM, disrupting the TGF-β-TβR-I-TβR-II signaling complex and inhibiting cell migration.

  • Mirzotamab

    Mirzotamab is an IgG1κ antibody targeting CD276/B7-H3 and is the naked antibody to Mirzotamab clezutoclax, consisting of 1320 amino acids.

  • diaminohydroxypropan...

    Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others